Meet the Investigator: Bryce Binstadt

Share on social media

Bryce Binstadt, MD, PhD

University of Minnesota

Innovation Research Award

A Novel TNFR1-Selective Small Molecule Inhibitor to Treat Rheumatoid Arthritis and Related Inflammatory Diseases

Dr. Binstadt and his collaborators are developing rheumatoid arthritis therapies that can be taken orally rather than injections and may have potentially fewer side effects than the current therapies.

“Our project has the potential to change therapies for patients with rheumatoid arthritis and other inflammatory diseases in the future.”

To hear more from Dr. Binstadt, watch the video above.

Donors like you make our important research funding possible. Consider donating today.